MarketCap
Facebook
X
TelegramQuarterly report 2022-Q1
added 12-16-2023
R1 RCM DPO Ratio 2011-2026 | RCM
Annual DPO Ratio R1 RCM
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 5.63 | 6.86 | 5.56 | 4.05 | 6.64 | 14.5 | 11.5 | 25 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 25 | 4.05 | 9.97 |
Quarterly DPO Ratio R1 RCM
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 5.96 | - | 6.53 | 6.96 | 7 | - | 8.22 | 9 | 8.09 | - | 7.62 | 7.49 | 5.79 | - | 4.12 | 4.76 | 5.62 | - | 5.88 | 6.82 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 9 | 4.12 | 6.66 |
DPO Ratio of other stocks in the Health information services industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Accolade
ACCD
|
14.4 | - | 0.29 % | $ 206 M |  USA |
 |
Phreesia
PHR
|
57.8 | $ 11.2 | -0.8 % | $ 611 M | USA |
 |
Cerner Corporation
CERN
|
103 | - | - | $ 27.9 B | USA |
 |
American Well Corporation
AMWL
|
10.4 | $ 5.71 | -0.7 % | $ 91.6 M | USA |
 |
Computer Programs and Systems
CPSI
|
17.8 | - | 4.4 % | $ 133 M | USA |
 |
Covetrus
CVET
|
41.9 | - | - | $ 2.94 B | USA |
 |
iCAD
ICAD
|
112 | - | - | $ 102 M | USA |
 |
Schrödinger
SDGR
|
35.6 | $ 11.42 | -1.3 % | $ 839 M | USA |
 |
Castlight Health, Inc.
CSLT
|
36.1 | - | -7.28 % | $ 227 M | USA |
 |
HMS Holdings Corp.
HMSY
|
11.7 | - | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
115 | - | - | $ 6.37 B | USA |
 |
NextGen Healthcare
NXGN
|
14.5 | - | - | $ 1.6 B | USA |
 |
Teladoc Health
TDOC
|
19.2 | $ 5.59 | 3.23 % | $ 985 M | USA |
 |
1Life Healthcare
ONEM
|
18 | - | - | $ 3.37 B | USA |
 |
Premier
PINC
|
28.6 | - | - | $ 2.33 B | USA |
 |
Omnicell
OMCL
|
27.6 | $ 34.87 | 1.19 % | $ 1.61 B | USA |
 |
OptimizeRx Corporation
OPRX
|
24.1 | $ 7.22 | 6.42 % | $ 124 M | USA |
 |
Evolent Health
EVH
|
27 | $ 2.27 | 0.44 % | $ 213 M | USA |
 |
MTBC
MTBC
|
36.4 | - | -0.58 % | $ 51.7 M | USA |
 |
GoodRx Holdings
GDRX
|
191 | $ 2.06 | 0.98 % | $ 795 M | USA |
 |
SCWorx Corp.
WORX
|
43.2 | $ 0.13 | 3.31 % | $ 190 K | USA |
 |
Signify Health
SGFY
|
57.5 | - | -0.02 % | $ 7.21 B | USA |
 |
Akerna Corp.
KERN
|
89.4 | - | - | $ 161 M | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
10.9 | - | -10.39 % | $ 886 M | USA |
 |
Zhongchao
ZCMD
|
32 | $ 1.85 | 2.16 % | $ 9.63 M |  China |
 |
HealthStream
HSTM
|
26.3 | $ 21.13 | 0.76 % | $ 642 M | USA |
 |
Health Catalyst
HCAT
|
23.8 | $ 1.1 | - | $ 76.9 M | USA |
 |
NantHealth
NH
|
86.1 | - | -46.64 % | $ 10.4 M | USA |
 |
HealthEquity
HQY
|
12.1 | $ 82.18 | 0.1 % | $ 7.08 B | USA |
 |
10x Genomics
TXG
|
32.5 | $ 20.69 | 4.42 % | $ 2.42 B | USA |
 |
Streamline Health Solutions
STRM
|
62 | - | - | $ 21.4 M | USA |
 |
Tabula Rasa HealthCare
TRHC
|
22.2 | - | - | $ 255 M | USA |
 |
Progyny
PGNY
|
171 | $ 17.8 | -1.41 % | $ 1.53 B | USA |
 |
Veeva Systems
VEEV
|
15.9 | $ 178.12 | -0.56 % | $ 29.2 B | USA |